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ABSTRACT
The skeleton is a dynamic tissue continuously adapting tomechanical stimuli. Althoughmatrix-embedded osteocytes are considered as
the key mechanoresponsive bone cells, all other skeletal cell types are principally exposed to macroenvironmental and microenviron-
mental mechanical influences that could potentially affect their activities. It was recently reported that Piezo1, one of the two mechan-
ically activated ion channels of the Piezo family, functions as a mechanosensor in osteoblasts and osteocytes. Here we show that Piezo1
additionally plays a critical role in the process of endochondral bone formation.More specifically, by targeted deletion of Piezo1 or Piezo2
in either osteoblast (Runx2Cre) or osteoclast lineage cells (Lyz2Cre), we observed severe osteoporosis with numerous spontaneous frac-
tures specifically in Piezo1Runx2Cremice. This phenotype developed at an early postnatal stage and primarily affected the formation of the
secondary spongiosa. The presumptive Piezo1Runx2Cre osteoblasts in this region displayed an unusual flattened appearance and were
positive for type X collagen. Moreover, transcriptome analyses of primary osteoblasts identified an unexpected induction of
chondrocyte-related genes in Piezo1Runx2Cre cultures. Because Runx2 is not only expressed in osteoblast progenitor cells, but also in pre-
hypertrophic chondrocytes, these data suggested that Piezo1 functions in growth plate chondrocytes to ensure trabecular bone forma-
tion in the process of endochondral ossification. To confirm this hypothesis, we generated mice with Piezo1 deletion in chondrocytes
(Col2a1Cre). These mice essentially recapitulated the phenotype of Piezo1Runx2Cre animals, because they displayed early-onset osteopo-
rosis with multiple fractures, as well as impaired formation of the secondary spongiosa with abnormal osteoblast morphology. Our data
identify a previously unrecognized key function of Piezo1 in endochondral ossification, which, togetherwith its role in bone remodeling,
suggests that Piezo1 represents an attractive target for the treatment of skeletal disorders. © 2020 The Authors. Journal of Bone andMin-
eral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
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Introduction
Skeletal development, growth, and remodeling are highlycomplex processes involving many different cell types with
unique functions.(1) Whereas a small subset of skeletal elements,
mostly in the skull, develops by intramembranous ossification,
where mesenchymal progenitor cells directly differentiate into
bone-forming osteoblasts, the majority of the axial and
appendicular skeleton develops by endochondral ossifica-
tion.(2,3) In this latter process the mesenchymal progenitor cells
initially condensate into cell clusters which differentiate into
chondrocytes to produce a cartilage intermediate that is subse-
quently replaced by bone. At the end of puberty, this modeling
phase is essentially replaced by bone remodeling, a physiologi-
cally relevant process, which is mediated by the coordinated
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
Received in original form May 8, 2020; revised form September 21, 2020; accepted October 11, 2020.
Address correspondence to: Thorsten Schinke, PhD, Department of Osteology and Biomechanics, University Medical Center Hamburg Eppendorf, Martinistrasse
52, Hamburg 20246, Germany. E-mail: schinke@uke.de
Additional Supporting Information may be found in the online version of this article.
*These authors contributed equally to this work.
Journal of Bone and Mineral Research, Vol. 00, No. 00, Month 2020, pp 1–16.
DOI: 10.1002/jbmr.4198
© 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research
(ASBMR).
1 n
activities of bone-resorbing osteoclasts and osteoblasts.(4) The
rate of bone remodeling is controlled, at least in part, by osteo-
cytes, representing terminally differentiated osteoblasts forming
an extensive cellular network within the mineralized bone
matrix.(5) Bone remodeling is strongly influenced by mechanical
loading, which is most evident in astronauts, who lose as much
as 2% of their bone mass each month when exposed to micro-
gravity, or in professional tennis players, who have up to 35%
more bone in their serving arm as in their contralateral arm.(6–8)
Moreover, absence of mechanical stimuli (eg, chronic bed rest
or low physical activity) negatively affects skeletal integrity in
the general population.
In this context osteocytes are considered the primary mechan-
osensing cell type of the skeleton, because they can sense
mechanical stimuli and react by differential expression of genes
affecting bone remodeling.(9,10) Importantly, however, osteocytes
are probably not the only skeletal cell types experiencingmechan-
ical forces. In fact, there is increasing evidence for an impact of
mechanobiology on various cells involved in developmental and
regenerative processes, and it is likely that the cellular processes
required for bone elongation are also controlled by mechanical
forces.(11,12) More specifically, longitudinal bone growth depends
on growth plate chondrocytes that undergo a complex multistep
differentiation process, which takes place in a nonvascularized
rigid extracellular matrix. After distinct morphological changes,
these cells become hypertrophic and eventually produce a calci-
fied cartilagematrix, which serves as a scaffold for trabecular bone
formation.(13,14) This region, termed primary spongiosa, is subse-
quently replaced by bone through the concerted action of osteo-
clasts and osteoblasts, which leads to the formation of trabecular
bone below the growth plates that is the secondary spongiosa.
Importantly, whereas the hematopoietic osteoclast progenitors
enter the primary and secondary spongiosa through the vascula-
ture, there is increasing evidence for the necessity of
chondrocyte-to-osteoblast transdifferentiation to generate the
osteoblasts required for trabecular bone formation.(15,16)
To understand the molecular bases of skeletal mechanosensa-
tion, we and others aimed at identifying specific proteins, which
are expressed by skeletal cells to sense mechanical forces and to
translate them into a biological response. Based on accumulating
evidence from nonskeletal cell types, there were two excellent
candidates to mediate mechanosensation in the skeleton, ie, the
members of the Piezo family, which were identified 10 years ago
asmechanically activated ion channels.(17) Both Piezo1 and Piezo2
represent large transmembrane proteins with the ability to homo-
multimerize, and their unique and huge transmembrane channel
structure enables them to be activated by stretching of cell
membranes.(18–20) Because Piezo channels are broadly expressed,
it is not surprising that their impact on mechanotransduction has
been shown for a variety of different cellular processes. For Piezo1
it was reported that its expression is required for the alignment of
endothelial cells along the direction of blood flow, for the control
of epithelial cell numbers through sensing of either mechanical
crowding or stretch, or for the response of innate immune cells
to hydrostatic pressure in the lung.(21–23) In contrast, Piezo2 was
reported to play a major role in Merkel cells and sensory neurons
of the skin, and as an airway stretch mechanosensor in the
lung.(24–26) Whereas the majority of these findings were obtained
in mousemodels, PIEZOmutations have also been found to cause
specific human disorders. More specifically, PIEZO1 mutations
were identified as a cause of dehydrated hereditary stomatocyto-
sis (gain-of-function) or lymphaticmalformation (loss-of-function),
whereas PIEZO2 mutations were found to cause Marden-Walker
syndrome (MWS) or distal arthrogryposis.(27–31)
The first evidence for an impact of Piezo proteins on the skele-
tonwas reported in 2019, where PIEZO1was identified as a genetic
determinant of estimated bone mineral density in humans.(32)
More recently, murine Piezo1 was identified to be required for
mechanosensation by osteoblasts at different stages of differenti-
ation, where it mediates the osteoanabolic influence of mechani-
cal loading and controls the crosstalk between osteoblasts and
osteoclasts.(33–35) Most recently, it was additionally reported that
the combined inactivationof Piezo1 and Piezo2 in limbmesenchy-
mal cells causes severe osteoporosis with accompanying fractures
in the appendicular skeleton of neonatal mice.(36) Although these
findings, all reported during the time of our own analyses, clearly
demonstrated a key role of Piezo1 for skeletal integrity, therewere
still many open questions that remain to be addressed. For
instance, the role of Piezo2 in the different skeletal cell types has
not been systematically studied. Moreover, because a function of
Piezo1 in osteoblast progenitors was uncovered by the use of
Prx1Cre mice, an impact on the axial skeleton could not be
analyzed here. Finally, and most importantly, it has not been
addressed so far, if the influence of Piezo1 on endochondral
ossification depends on its expression in chondrocytes.
Here we describe a systematic analysis of mouse models lack-
ing Piezo1 and/or Piezo2 in different skeletal cell types. We
thereby confirmed that Piezo1 is required for mechanosensation
by osteocytes, and we additionally demonstrate a previously
unrecognized function of Piezo1 in growth plate chondrocytes,
which is required for trabecular bone acquisition. Our data
complement the previous studies involving other mouse lines
to provide a near complete knowledge on the key functions of
Piezo proteins in skeletal development, growth, and remodeling.
Materials and Methods
Cell culture
Primary osteoblasts were isolated by sequential collagenase-
dispase II digestion from the calvariae of 5-day-old mice and dif-
ferentiated in the presence of α-Minimum Essential Medium
Eagle (α-MEM; Sigma-Aldrich, St. Louis, MO, USA) supplemented
with 10% FCS (Hyclone Laboratories, Logan, UT, USA), 1% Pen/-
Strep (Gibco, Grand Island, NY, USA), 50 μg/mL ascorbic acid
and 10mM β-glycerophosphate as described.(37) After 2 days of
differentiation, cells were serum-starved overnight and then
treated for 6 hours with Yoda1 (5μM; Tocris Bioscience, Bristol,
UK; 5586). For the generation of primary osteoclasts, bone mar-
row was flushed out of the femurs from 12-week-old mice. Cells
were then cultured α-MEM (10% FBS [Gibco], 1% Pen/Strep) sup-
plemented with 10nM 1,25-dihydroxyvitamin-D3. At day 4 after
seeding, M-CSF (PeproTech, Rocky Hill, NJ, USA; 315–02) and
sRANK Ligand (PeproTech; 315–11) were added to a final concen-
tration of 20 and 40 ng/mL, respectively. Mouse preosteoblastic
calvarial MC3T3-E1 cells (CRL-2593; American Type Culture
Collection (ATCC), Manassas, VA, USA) were cultured in α-MEM
(Lonza, Basel, Switzerland; BE12-169F) supplemented with 10%
FCS (Merck Millipore, Burlington, MA, USA; S0605) and incubated
in 5% CO2 and at 37C. Chondrogenic ATDC5 cells (Sigma-
Aldrich; 99072806) were grown in Dulbecco’s Modified Eagle
Medium/Ham’s F12 Nutrient mixture (DMEM/F12; Thermo Fisher
Scientific, Waltham, MA, USA; 21331-020) supplementedwith 5%
FCS, 10 μg/mL transferrin (Sigma-Aldrich; T8158), and 30nM
sodium selenite (Sigma-Aldrich; S5261).
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Expression analysis
RNA was isolated using the RNeasyMini kit (QIAGEN, Valencia, CA,
USA), and DNase I digestion was performed according to the man-
ufacturer’s instructions. Concentration and quality of RNA were
measured using a NanoDrop ND-1000 system (NanoDrop, Thermo
Fisher Scientific, Waltham, MA, USA) and the TapeStation 2200 sys-
tem (Agilent Technologies, Santa Clara, CA, USA). For genomewide
expression analysis, 100 ng of total RNAwere used for the synthesis
of proprietary labeled 2nd-cycle single-stranded complementary
DNA (ss-cDNA) utilizing the ClariomD assay, mouse (Thermo Fisher
Scientific). Samples were prepared according to themanufacturer’s
GeneChip™WT PLUS reagent kit manual (document 703174; revi-
sion A.0). For Gene Chip hybridization, 5.5 μg of fragmented and
labeled cDNA was incubated in hybridization solution at 45C for
16 hours, before the Gene Chips (Clariom D, mouse) were washed
using the Affymetrix Fluidics Station 450 (Affymetrix, Santa Clara,
CA, USA). Microarrays were scanned with the Affymetrix Gene Chip
Scanner 7G, and the signals were analyzed with the Transcriptome
Analysis Console software (TAC 4.0; Thermo Fisher Scientific) using
default analysis settings (version 1) andGene + Exon – signal space
transformation–robust multiarray analysis (SST-RMA) as summari-
zation. The gene expression data have been deposited at the
GEO database (National Center for Biotechnology Information
[NCBI], Bethesda, MD, USA; https://www.ncbi.nlm.nih.gov/geo/)
with accession number GSE138159 (primary osteoblasts) and
GSE138160 (MC3T3-E1 cells). For qRT-PCR expression analysis,
1 μg of RNA was reversed transcribed using Verso cDNA Synthesis
Kit (Thermo Fisher Scientific) according to the manufacturer’s
instructions. Quantitative expression analysis was performed using
a StepOnePlus system and predesigned TaqMan gene expression
assays (Applied Biosystems, Foster City, CA, USA).Gapdh expression
was used as an internal control. Relative quantification was per-
formed according to the comparative threshold cycle (ΔΔCT)
method, and results were expressed in the linear form using the
delta-delta comparative threshold cycle formula (2−ΔΔCT).
Mechanical loading experiments in vitro
MC3T3-E1 cells were plated at a density of 10,000 cells/cm2 on
collagen-coated glass slides (Flexcell, Burlington, NC, USA;
CS-C). Cells were subjected or not subjected (static control) to
mechanical stimulation by laminar fluid flow (LFF) with a shear
stress of 10 dynes/cm2 for 1 hour using the Streamer System
(FlexCell; STR-4000). RNA samples were obtained immediately
(0 hours), 2 and 4 hours after LFF.
RNA interference and treatment with Yoda1
MC3T3-E1 cells were seeded at a density of 10,000 cells/cm2 on
collagen-coated glass slides (FlexCell; CS-C). Silencer Select Piezo1
siRNA (Thermo Fisher Scientific; s107968) or Silencer Negative
Control siRNA (Thermo Fisher Scientific; AM4636) was added at a
concentration of 5 pmol/μL to the cells in serum-reduced (1%
FCS) α-MEM without antibiotics using Lipofectamine (Thermo
Fisher Scientific; 13778030) in Opti-MEM (Thermo Fisher Scientific;
31985062) for transfection. Cellswere incubated in 5%CO2 at 37C
for 48 hours before LFF was applied. Treatment with Yoda1 (5μM)
was performed in serum-reduced (1% FCS) α-MEM for 6 hours.
DMSO vehicle was used at a concentration of 0.01% as control.
Mouse models
Generation and genotyping Piezo1fl/fl and Piezo2fl/fl mice (the
latter ones kindly provided by A. Patapoutian The Scripps
Research Institute, La Jolla, CA, USA.) have been described previ-
ously.(22,26) The same applies for the four Cre-expressing mouse
lines that were used in this study.(38–41) Whereas Lyz2Cre
(#004781), Dmp1Cre (#023047), and Col2a1Cre (#003554) mice
were obtained by the The Jackson Laboratory (Bar Harbor, ME,
USA), Runx2Cre mice were kindly provided by J. Tuckermann
(Ulm University, Ulm, Germany). To rule out any possible influ-
ence of genetic background, all analyses were performed with
the corresponding Cre-negative littermate controls. Mice were
housed in a specific pathogen-free environment with a 12-hour
light/dark cycle, 45% to 65% relative humidity and 20C to
24C ambient temperature in open or individually ventilated
cages with wood shavings bedding and nesting material in
groups not surpassing six animals. Mice had ad libitum access
to tap water and standard rodent chow (1328P; Altromin Spezial-
futter GmbH & Co. KG, Lage, Germany). Animal care and all
experimental procedures were performed with approval from
the animal care committees of the University Medical Center
Hamburg-Eppendorf (N18/073, Org869).
Ex vivo calibration and mechanical loading in vivo
The mechanical loading regime was calibrated as described.(42)
Briefly, strain gauges were applied to the lateral medial surface
of the ulnas of 12-week-old female Piezo1fl (n = 6) and Piezo1-
Dmp1Cre (n = 6) mice postmortem. The right ulna was positioned
in the loading apparatus and the load required to produce a
peak surface strain of 2000 microstrain (μstrain) during locomo-
tion were recorded. Generated strains were different between
the genotypes, wherefore cyclic axial compression of the right
ulna was performed using a frequency of 2 Hz and a maximum
load of 1.5 N and 0.62 N in 12-week-old female Piezo1fl and
Piezo1Dmp1Cre mice, respectively. After ex vivo calibration,
in vivo loading was performed on ulnas of 12-week-old female
Piezo1fl (n = 6) and Piezo1Dmp1Cre (n = 6) mice during anesthesia
on three consecutive days for 1 min each. The left ulnas were
used as nonloaded controls. All mice received a subcutaneous
injection of Calcein green (0.03 g/kg) on day 3 and Alizarin red
(0.045 g/kg) on day 12 and were euthanized on day 16. Animals
were allocated to the different groups based on their genotype.
Because of the different maximum loads for each genotype,
investigators were not blinded during the allocation and animal
handling. Blinding was given for endpoint measurements after
the animals were euthanized. No adverse events were observed.
These experimental procedures were performed with approval
from the animal care committee of Baden-Württemberg
(Regierungspräsidium Tübingen, No. 1388).
Micro-computed tomography and histomorphometry
of ulnas
Ulnas were scanned using a micro-computed tomography
(μCT) device (Skyscan 1172; Bruker, Kontich, Belgium) as
described (8 μm, 50 kV, 200 mA, hydroxyapatite phantoms:
250 and 750 mg hydroxyapatite [HA]/cm3).(43) A 1-mm-thick
section of the mid-diaphyseal cortical bone, beginning 3 mm
distally from the ulna head, was analyzed as region of interest.
Using a fluorescent microscope (Leica, Wetzlar, Germany;
DMI6000 B), periosteal bone formation rate (BFR/BS) was deter-
mined in 10-μm-thick cross-sections of the left and right ulnas
using image analysis software (Leica; MMAF 1.4.0) with an
interlabel time (Ir.L.t) of 9 days. BFR was calculated as
described.(42)
Journal of Bone and Mineral Research A CRITICAL ROLE OF PIEZO1 IN CHONDROCYTES 3 n
Skeletal phenotyping
Dissected skeletons were fixed in 3.7% PBS-buffered formalde-
hyde for 18 hours, before they were stored in 80% ethanol. After
initial assessment by contact X-ray, the lumbar vertebral bodies
L1 to L4 and one tibia were dehydrated in ascending alcohol con-
centrations and then embedded in methylmethacrylate for
undecalcified histology as described.(44) For μCT scanning, we
used the left femurs that were scanned using a μCT 40 desktop
cone-beam microCT (SCANCO Medical AG, Brüttisellen, Switzer-
land) with a voxel size of 10 μm (1000 projections per slice with
2048 samples and 200-s sample time at a tube energy of
55 kVp with an intensity of 145 mA). Reconstructed slices were
analyzed using the SCANCO MicroCT software suite. Trabecular
bone was analyzed in the distal metaphysis in the region 2.5 to
0.5 mm proximal of the growth plate using the evaluation script
‘UCT_EVALUATIONV6_MULTIAUTO’. This script was also used for
analysis of cortical bone at the middle of the diaphysis for a
length a 1 mm. Pelvis bones were scanned and evaluated utiliz-
ing the same protocol with the volume of interest extended to
include the whole bone. The pelvic angle was determined on
aligned 3D reconstructions. Staining of skeletons with Alcian
blue and Alizarin red was performed as described.(45) To allow
quantification of the BFR, all animals received two doses of cal-
cein (30 mg/kg i.p.; Sigma-Aldrich) 10 and 3 days before eutha-
nasia. Histological sections of 4 μm thickness from the sagittal
plane were stained by Toluidine blue, by von Kossa/van Gieson
or by Masson-Goldner staining procedures as described.(44) His-
tomorphometry was performed according to the ASBMR guide-
lines using the OsteoMeasure histomorphometry system
(OsteoMetrics, Decatur, GA, USA).(46) Quantification of the osteo-
cyte canalicular network was performed on plastic-embedded
tibia specimens by acid etching and subsequent scanning
electron microscopy as described.(47) All quantitative analyses
were performed in a blinded fashion. To determine collagen pro-
duction and processing we measured serum concentrations of
procollagen type 1 N propeptide (P1NP) and carboxy-terminal
propeptide of type 1 procollagen (P1CP) by ELISA (Cloud-Clone
Corp, Houston, TX, USA; Sea957Mu and Sea570Mu).
Immunohistochemistry
For immunohistochemical analysis of collagen type X, dissected
skeletons were first fixed in 3.7% PBS-buffered formaldehyde,
before they were stored in 80% ethanol, decalcified in EDTA, and
embedded in paraffin. Sections of 5 μm thickness were cut, and
after deparaffinization, slides were pretreated with pepsin (S3002;
DAKO, Carpinteria, CA, USA) for enzymatic antigen retrieval. Endog-
enous peroxidase activity was blocked through incubation with 3%
H2O2 in methanol. Using the DAKO ARK™ (Animal Research Kit,
K3954; DAKO), slides were incubated with the primary antibody
to collagen type X (2031501001, 1:20; Quartett, Berlin, Germany)
overnight at 4C. Sections were treated with streptavidin–
horseradish peroxidase (HRP) andperoxidase activitywas visualized
using the DAB+ substrate-chromogen solution. Finally, slides were
counterstained with hematoxylin and mounted.
In vitro endochondral ossification assay
Chondrogenic ATDC5 cells were seeded at a density of 8000
cells/well in 24-well plates in chondrogenic DMEM/Ham’s F12
medium supplemented with 5% FCS, 10 μg/mL transferrin,
30nM sodium selenite, 0.2mM ascorbate-2-phosphate (Sigma;
A8960) and 10 μg/mL insulin (Sigma; I9278). Cells were
incubated in 6% O2 at 37C. At day 7, chondrogenic medium
was replaced by osteogenic α-MEM supplemented with 10%
FCS, 10mM β-glycerophosphate (Sigma; G5422) 0.2mM ascor-
bate 2-phosphate, 100 ng/mL recombinant BMP2 (Thermo
Fisher Scientific; PHC7145), with or without 5μM Yoda1 and cells
were cultivated in 21% O2 at 37C until day 10. RNA lysates were
obtained at days 8, 9, and 10 of cultivation. Alternatively, the
same culture conditions were applied with or without addition
of 4μM GsMTx4 (Abcam, Cambridge, UK; ab141871) to the
medium. In another set of experiments, we transfected the cells
at day 7 with Silencer Select Piezo1 siRNA or Silencer Negative
Control siRNA, as described for MC3T3-E1 cells in the section
RNA interference and treatment with Yoda1.
Statistical analysis
All data are presented as box plots, either median with interquar-
tile range where whiskers indicate minimum to maximum or
median and minimum to maximum. For the comparison of two
groups, statistical analysis was performed using unpaired, two-
tailed Student’s t test. For the comparison of multiple groups,
we used ANOVA (Graph Pad Prism; GraphPad Software, Inc., La
Jolla, CA, USA). In both cases, p values <.05 were considered
statistically significant.
Results
Piezo1 activation in osteoblasts induces the expression of
mechanoresponsive genes
To uncover a potential impact of Piezo proteins on skeletal cell
types, we first analyzed transcription of Piezo1 and Piezo2 in differ-
ent murine tissues and primary bone cells. Whereas Piezo1 dis-
played the highest expression in early differentiating osteoblast
progenitors (Fig. 1A), Piezo2 expression was induced during the
osteoclastogenic differentiation of bone marrow cells (Fig. 1B).
Based on these initial findings, we analyzed the transcriptional
response of primary osteoblasts towards the Piezo1-specific ago-
nist Yoda1.(48) More specifically, we treated three independent
sets of primary calvarial osteoblasts at day 2 of osteogenic differ-
entiation with Yoda1 (5μM) for 6 hours to identify immediate tran-
scriptional targets by genomewide expression analysis (Fig. 1C,D).
Interestingly, two of the most strongly induced genes were Ptgs2
(encoding cyclooxygenase-2) and Serpine1, both known to be
transcriptionally activated in bone cells by mechanical loading.(7)
Moreover, a single whole-transcriptome analysis of MC3T3-E1
osteoblasts 0 and 4 hours after mechanical stimulation with LFF
also induced Ptgs2 and Serpine1 expression (Fig. 1E,F; Supplemen-
tary Fig. 1A). We additionally analyzed our data sets regarding the
regulation of previously established Piezo1-regulated genes,(33–35)
but here we only observed nonsignificant or very moderate
differences (Supplementary Fig. 1B,C).
As confirmed by qRT-PCR, LFF caused a significant induction
of Piezo1 expression in MC3T3-E1 osteoblasts, not immediately,
but 2 and 4 hours after mechanostimulation (Fig. 1G). To analyze
if Piezo1 activity is required for mechanosensation by osteo-
blasts, we examined the influences of Yoda1 and LFF on gene
expression after application of siRNA-mediated knockdown of
Piezo1 in MC3T3-E1 osteoblasts. We observed that the
Yoda1-mediated induction of Ptgs2 and Serpine1 was strongly
reduced by siRNA-mediated knockdown of Piezo1, as expected
(Fig. 1H). In contrast, there was only a minor reduction in the
LFF-mediated induction of Serpine1, whereas Ptgs2 expression
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Fig 1. Piezo1 activation in osteoblasts induces the expression of mechanoresponsive genes. (A) qRT-PCR expression analysis of Piezo1 and (B) Piezo2 in
different murine tissues and in primary bone cells at different stages of ex vivo differentiation. (C) Volcano plot showing differentially expressed genes
in wild-type primary osteoblasts treated with the Piezo1 agonist Yoda1 (5μM) or DMSO for 6 hours. (D) Heat map showing the five genes with the stron-
gest induction after Yoda1 administration, as well as Piezo1 and Piezo2. Data are shown as log2 expression values. (E) Scatter plots of single whole-
transcriptome analyses of MC3T3-E1 cells 4 hours after mechanical stimulation by LFF. (F) Heat map illustrating the expression of a selection of genes
in MC3T3-E1 cells 0 and 4 hours after mechanical stimulation by LFF. Data are shown as log2 expression values. (G) qRT-PCR analysis of Piezo1 expression
in MC3T3-E1 cells under static (S) conditions and 0, 2, and 4 hours post-LFF. (H) qRT-PCR analysis of Piezo1, Ptgs2, and Serpine1 in MC3T3-E1 cells treated
with Yoda1 (5μM) and after siRNA-mediated KD of Piezo1. (I) qRT-PCR analysis of Piezo1, Ptgs2, and Serpine1 in MC3T3-E1 cells 4 hours after mechanical
stimulation by LFF and after siRNA-mediated knockdown of Piezo1. Data are median, minimum to maximum (n = 3), p values obtained by unpaired
two-tailed t-test. KD = knockdown; LFF = laminar fluid flow; Obl = osteoblasts; Ocl = osteoclasts; S = static.
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was unaffected by Piezo1 knockdown 0 and 4 hours after expo-
sure to LFF (Fig. 1I; Supplementary Fig. 1D). This unexpected dis-
crepancy led us to generate mouse models with Piezo1 and/or
Piezo2 inactivation in specific skeletal cell populations.
Runx2Cre-mediated Piezo1 deletion causes a more severe
osteoporotic phenotype than Dmp1Cre-mediated Piezo1
deletion
We first took advantage of Dmp1Cre mice to inactivate the two
Piezo proteins in terminally differentiated osteoblasts, that is
osteocytes.(38) By undecalcified histology of the lumbar vertebral
bodies and μCT analysis of the femoral bones, we observed that
Piezo1Dmp1Cre mice displayed reduced trabecular and cortical
bone mass, a phenotype that was not exacerbated by the com-
bined deletion of both Piezo genes (Supplementary Fig. 2). The
deduced hypothesis that only Piezo1 is required for osteocyte
mechanosensation was subsequently confirmed by an in vivo
ulna loading experiment (Supplementary Fig. 3). Although these
data are consistent with a recent study, where Piezo1Dmp1Cremice
were subjected to tibia loading,(34) it was additionally important
to analyze the cellular consequences of Piezo1 deletion in osteo-
cytes. In fact, whereas we did not detect significant changes in
osteocyte number or the number of canalicular extensions after
acid-etching of Piezo1fl and Piezo1Dmp1Cre cortical bone
(Supplementary Fig. 4A,B), the osteoblast population was obvi-
ously affected. More specifically, we observed that trabecular
osteoblasts in Piezo1Dmp1Cre mice did not generally exhibit the
characteristic cuboidal shape, but showed a flattened appear-
ance (Supplementary Fig. 4C). Together with the initially
observed high expression of Piezo1 in osteoblast progenitor
cells, these data suggested that Piezo1 might have an additional
function in osteoblast differentiation, independent of its role in
osteocyte mechanosensation.
To delete Piezo1 and/or Piezo2 in osteoblast progenitor cells
we took advantage of Runx2Cre mice, where recombination,
unlike in Prx1Cre mice, occurs in all skeletal elements.(39) More-
over, because Piezo2was found to be expressed in differentiated
osteoclasts, we additionally inactivated the two Piezo proteins in
osteoclast lineage cells using Lyz2Cre mice.(40) We generated
Piezo1Runx2Cre, Piezo1Lyz2Cre, Piezo2Runx2Cre, and Piezo2Lyz2Cre mice
and analyzed their skeletal phenotypes in comparison to their
respective Cre-negative littermates at 12 weeks of age. By unde-
calcified histology of vertebral bodies we identified a remarkable
reduction of trabecular bone mass specifically in the Piezo1-
Runx2Cre mice of both sexes (Fig. 2A,B). In comparison to Piezo1-
Dmp1Cre mice, this phenotype was not only more severe, but
also different, as it was strongly pronounced in the trabecular
bone compartment below the growth plates (Supplementary
Fig. 5). Whereas Piezo1Lyz2Cre and Piezo2Lyz2Cre mice did not dis-
play a detectable skeletal phenotype, a moderate reduction of
trabecular bone mass was also identified in female, but not in
male Piezo2Runx2Cre mice. These trabecular bone phenotypes
were confirmed by μCT analysis of the femurs, where we addi-
tionally detected reduced cortical thickness and increased corti-
cal porosity in Piezo1Runx2Cre mice (Fig. 2C–E). Piezo1Runx2Cre
femurs were also significantly shorter in comparison to Piezo1fl
controls (Fig. 2F).
The most striking aspect of the Piezo1Runx2Cre phenotype was,
however, the high number of spontaneous fractures (Fig. 3A).
More specifically, in 12-week-old Piezo1Runx2Cre mice, we identi-
fied an average of five rib fractures and one hindlimb fracture
per animal (Fig. 3B). In contrast, we rarely and never detected
fractures in Piezo1Dmp1Cre and Piezo2Runx2Cre mice, respectively.
As an additional pathology in Piezo1Runx2Cre mice we identified
dysplasia of the pelvic bone on X-ray images, which was sup-
ported by μCT analysis, where we observed an increased pelvic
porosity and angle (Fig. 3C–E). Interestingly, a similar pathology
was previously reported for mice subjected to microgravity for
1 month.(49) Finally, it is noteworthy that we did not detect an
alteration of calvarial thickness or porosity in 12-week-old Piezo1-
Runx2Cremice (Fig. 3F,G), suggesting that deletion of Piezo1 during
early stages of osteoblast differentiation specifically affects
bones that are formed through endochondral ossification.
Because we detected a moderate trabecular bone mass
reduction in female Piezo2Runx2Cremice, we additionally analyzed
Piezo1;Piezo2Runx2Cre mice to investigate if the combined loss of
both Piezo proteins would exacerbate the Piezo1Runx2Cre pheno-
type. Because Piezo1;Piezo2Runx2Cre mice were not viable until
the age of 12 weeks, we analyzed them at a younger age. Here
we identified a high incidence of fractures at 3 and 6 weeks of
age (Supplementary Fig. 6A–C). In 6-week-old Piezo1;Piezo2-
Runx2Cre mice we additionally identified reduced skeletal growth,
near absence of trabecular bone, but no difference toward
Piezo1;Piezo2fl littermates in terms of growth plate morphology
(Supplementary Fig. 6D–H). This unexpected early-onset pheno-
type did not only demonstrate that Piezo2 can compensate, to
some extent, for the loss of Piezo1, but also suggested a critical
role for Piezo1 in bone development by endochondral
ossification.
Piezo1 controls the expression of chondrogenic genes
To understand the molecular basis of the bone phenotype of
Piezo1Runx2Cre mice, we analyzed the ex vivo behavior of Piezo1-
Runx2Cre osteoblast progenitor cells. In bone marrow cultures we
observed, by Alizarin red staining of mineralized matrix, 10 days
after addition of ascorbic acid and β-glycerophosphate, a signif-
icant (p = .018) reduction by 40% in Piezo1Runx2Cre cultures.
Because we also observed a cell-autonomous osteogenesis
defect in primary calvarial osteoblasts isolated from Piezo1-
Runx2Cre mice (Fig. 4A), we focused on their further analyses for
two major reasons. First, there are far fewer other cell types in
calvaria-derived cultures, which enhanced the possibility to
uncover differentially expressed genes in independently isolated
cultures. Second, incomplete closure of cranial sutures had been
described for newborn Piezo1OcnCre mice,(33) thereby suggesting
an impact of Piezo1 deficiency on craniofacial bone develop-
ment. We therefore performed whole-transcriptome analyses
with three independent Piezo1fl and Piezo1Runx2Cre primary cal-
varial osteoblast cultures at day 2 of differentiation. We thereby
identified 15 genes with significant differential expression, one
of them Piezo1, displaying the expected reduction in Piezo1-
Runx2Cre osteoblasts (Fig. 4B). Unexpectedly, we detected
increased expression of Sox9 and Cdkn1c, both required, in mice
and humans, for the coordinated differentiation of growth plate
chondrocytes during endochondral bone formation.(50,51) More-
over, we observed increased expression of Deptor, encoding an
inhibitor of the mammalian target of rapamycin complex 1 and
2 (mTORC1, mTORC2) that induces autophagy and influences
hypertrophic chondrocyte differentiation.(52,53) The respective
transcriptome changes were confirmed by qRT-PCR, and here
we additionally detected increased expression of other chondro-
cyte differentiation markers, that is Acan and Col10a1 (Fig. 4C). In
contrast, Vegfa, encoding an angiogenic protein essential for
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endochondral bone formation,(54) was transcriptionally downre-
gulated in Piezo1Runx2Cre osteoblasts.
As an established in vitro model of endochondral
ossification,(55) we next cultured ATDC5 chondrogenic cells with
or without Yoda1 starting on day 7 of differentiation, when chon-
drogenic media were changed to osteogenic media (Fig. 4D).
After 3 days of Yoda1 treatment, ie, at day 10 of differentiation,
we did not only observe significantly increased Piezo1 expres-
sion, but also a strong reduction in the expression of Col10a1
(Fig. 4E). Although Sox9, Acan, and Col2a1 remained transcrip-
tionally unchanged, Yoda1 treatment also caused a reduction
in Deptor and Cdkn1c expression, as well as a transcriptional acti-
vation of Vegfa (Fig. 4F). Of note, Vegf induction was also
observed in primary osteoblasts after administration of Yoda1,
Fig 2. Runx2Cre-mediated Piezo1 deletion causes a low bonemass phenotype. (A) Representative images after von Kossa staining of lumbar spine sections of
12-week-old female control, Piezo1Runx2Cre, Piezo1Lyz2Cre, Piezo2Runx2Cre, and Piezo2Lyz2Cre mice. (B) Quantification of the trabecular BV/TV in lumbar spine sec-
tions of 12-week-old female and male mice Piezo1Runx2Cre (n = 6 female; n = 4 male), Piezo2Runx2Cre (n = 6 female; n = 6 male), Piezo1Lyz2Cre (n = 6 female;
n = 8 male), and Piezo2Lyz2Cremice (n = 6 female; n = 3 male), in comparison to their respective Cre-negative Piezo1fl or Piezo2fl littermate controls. (C) Repre-
sentative μCT images showing whole femurs (top), cortical (middle), and trabecular bone (bottom) from 12-week-old female control, Piezo1Runx2Cre, Piezo2-
Runx2Cre, Piezo1Lyz2Cre, and Piezo2Lyz2Cre mice. (D) μCT-based quantification of the trabecular BV/TV in 12-week-old female and male Piezo1Runx2Cre (n = 6
female; n = 4 male), Piezo2Runx2Cre (n = 6 female; n = 6 male), Piezo1Lyz2Cre (n = 6 female; n = 8 male), and Piezo2Lyz2Cremice (n = 6 female; n = 3 male), in com-
parison to their respectiveCre-negative Piezo1fl or Piezo2fl littermate controls. (E,F) μCT-based quantification of Ct.Th, Ct.Po (E), and femur length (F) in the same
mice. Data are median with interquartile range, whiskers indicate minimum to maximum, p values obtained by unpaired two-tailed t test. BV/TV = bone vol-
ume per tissue volume; Ct.Po = cortical porosity; Ct.Th = cortical thickness.
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where Gene Ontology (GO) analysis of differentially expressed
genes identified a significant enrichment for genes involved in
VEGF signaling (Supplementary Fig. 7). We next addressed the
question if siRNA-mediated knockdown of Piezo1 in ATDC5 cells
would also affect the expression of chondrogenic markers. We
therefore transfected the cells at day 7 of differentiation and
monitored gene expression 2 and 3 days thereafter. Although
the Piezo1 knockdown was less pronounced compared to
Fig 3. Runx2Cre-mediated Piezo1 deletion causes spontaneous fractures and pelvic dysplasia. (A) Representative X-ray images of 12-week-old female
Piezo1fl and Piezo1Runx2Cremice. White boxes indicatemagnified areas, showingmultiple rib fractures (empty arrowheads), femoral fractures (closed arrow-
heads), and pelvic dysplasia (arrow). (B) Quantification of rib and hindlimb fractures in 12-week-old female and male Piezo1Runx2Cre (n = 6 female, n = 4
male), Piezo1Dmp1Cre (n = 6 female, n = 7male), and Piezo2Runx2Cremice (n = 6 female, n = 6male). (C) Representative μCT images of pelvis and ischium from
12-week-old female Piezo1fl and Piezo1Runx2Cre mice. (D) Schematic representation of the pelvic bone, the ischium (green) and the pelvic angle. (E) Quan-
tification of Pelvis Th., Pelvis Po., and pelvic angle in 12-week-old female Piezo1fl (n = 6) and Piezo1Runx2Cremice (n = 4). (F) Representative μCT images of the
skull from 12-week-old female Piezo1fl and Piezo1Runx2Cre mice. (G) μCT-based quantification of Calv.Th and Calv.Po in 12-week-old female Piezo1fl (n = 6)
and Piezo1Runx2Cre mice (n = 6). Data are median with interquartile range, whiskers indicate minimum to maximum, p values obtained by unpaired
two-tailed t test. Calv.Po = calvarial porosity; Calv.Th = calvarial thickness; Pelvis Po. = pelvic porosity; Pelvis Th. = pelvic thickness.
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MC3T3-E1 cells, we observed a moderate induction of Col10a1,
Acan, and Col2a1 (Supplementary Fig. 8A). To confirm these data
through an independent experimental approach, we added
GsMTx4 (4μM), a spider venom peptide that is commonly used
to inhibit Piezo1,(33) to the culture medium. This treatment did
not only increase the expression of the above-mentioned chon-
drogenic markers, but also of Deptor and Sox9 (Supplementary
Fig. 8B). Taken together, these fully unexpected data, based on
an unbiased analysis of primary calvarial osteoblasts, led us to
focus on the role of Piezo1 in endochondral ossification and to
analyze, as a next step, Piezo1Runx2Cre mice at younger age.
Runx2Cre-mediated Piezo1 deletion impairs secondary
spongiosa formation
To identify the age of onset of the Piezo1Runx2Cre phenotype,
we first analyzed newborn Piezo1fl and Piezo1Runx2Cre litter-
mates. Here we did not detect obvious skeletal defects or frac-
tures immediately after birth (Fig. 5A). Moreover, newborn
Piezo1Runx2Cre did not display the calvarial bone defect previ-
ously described for Piezo1OcnCre mice (Fig. 5B), and their tra-
becular bone mass was not decreased compared to Piezo1fl
littermates in vertebral body sections (Fig. 5C). However,
Fig 4. Piezo1 controls the expression of chondrogenic genes. (A) Alizarin red staining and OD quantification of matrix mineralization in primary calvarial
osteoblast cultures from Piezo1fl and Piezo1Runx2Cre mice at day 10 of differentiation. (B) Graphic representation of all genes displaying significantly
increased or decreased expression Piezo1Runx2Cre primary calvarial osteoblasts after whole-transcriptome analyses from three independent experiments.
(C) Relative qRT-PCR expression analysis for the indicated genes data in Piezo1Runx2Cre primary osteoblasts. The red dotted line indicates the expression in
Piezo1fl control cultures. (D) Setup of the in vitro endochondral ossification assay with differentiating ATDC5 cells treated with or without Yoda1 (5μM). (E)
qRT-PCR expression analysis of Piezo1 and Col10a1 in chondrogenic ATDC5 cells at day 8, 9, and 10 of differentiation, after treatment with vehicle (DMSO)
or Yoda1. (F) qRT-PCR expression analysis of Deptor, Cdkn1c, Sox9, Acan, Col2a1, and Vegf in the same samples. Data are either median with interquartile
range, whiskers indicate minimum to maximum or median and minimum to maximum, p values obtained by unpaired two-tailed t test. OD = optical
density.
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Fig 5. The Piezo1Runx2Cre skeletal phenotype develops in an early postnatal phase. (A) Representative images of Alizarin red/Alcian blue staining from
Piezo1fl and Piezo1Runx2Cre full skeletons at birth (P0). (B) Representative Alizarin red/Alcian blue staining from Piezo1fl and Piezo1Runx2Cre calvaria and quan-
tification of distance between parietal bones at birth (P0). (C) Representative von Kossa staining and quantification of trabecular BV/TV of lumbar spine
sections from 1-day-old female Piezo1fl (n = 4) and Piezo1Runx2Cre mice (n = 3). (D) Representative images of X-rays and Alizarin red/Alcian blue staining
of Piezo1fl and Piezo1Runx2Cre at P5 showing multiple rib fractures (arrows). (E) Representative X-ray images of female 2-week-old Piezo1fl and Piezo1Runx2Cre
mice showingmultiple rib fractures (empty arrowheads) and a femoral fracture (full arrowhead). (F) Quantification of rib and hindlimb fractures in 2-week-
old female Piezo1Runx2Cre (n = 3) and Piezo1;Piezo2Runx2Cremice (n= 4). (G) X-ray–based quantification of length of LS, Fe, and Ti in 2-week-old female Piezo1fl
(n = 4) and Piezo1Runx2Cremice (n = 3). (H) Representative von Kossa staining and quantification of trabecular BV/TV of lumbar spine (top) and tibia sections
(bottom) from 2-week-old female Piezo1fl (n = 4) and Piezo1Runx2Cremice (n = 3). (I) Quantification of the PZ, HZ, and TW in 2-week-old female Piezo1fl (n = 4)
and Piezo1Runx2Cre mice (n = 3). (J) Immunohistochemistry staining for collagen type X showing ColX-positive (full arrowheads) and ColX-negative (empty
arrowheads) trabecular bone cells in LS sections of 2-week-old male Piezo1fl and Piezo1Runx2Cre mice. The localization of the HZ as well as the PS and SS is
indicated on the left. Data are median with interquartile range, whiskers indicate minimum to maximum, p values obtained by unpaired two-tailed t test.
BV/TV = bone volume per tissue volume; Fe = femurs; HZ = hypertrophic zone; LS = lumbar spine; P0 = postnatal day 0; PS = primary spongiosa; PZ =
proliferative zone; SS = secondary spongiosa; Ti = tibias; TW = total growth plate width.
Journal of Bone and Mineral Researchn 10 HENDRICKX ET AL.
already at postnatal day 5 (P5) the first rib fractures appeared
(Fig. 5D), and at 2 weeks of age all Piezo1Runx2Cre mice dis-
played skeletal fractures (Fig. 5E). Importantly, the number of
fractures at that age was comparable to Piezo1;Piezo2Runx2Cre
mice (Fig. 5F), thereby confirming that Piezo1 is the most rele-
vant Piezo channel to achieve skeletal integrity. In 2-week-old
Piezo1Runx2Cremice, we additionally detected shortening of the
long bones (Fig. 5G), suggesting impaired endochondral
Fig 6. Runx2Cre-mediated Piezo1 deletion impairs endochondral ossification and secondary spongiosa formation. (A) Schematic representation of the GP
with PZ and HZ as well as the areas comprising the PS and SS. (B) Representative tibia sections of 12-week-old female Piezo1fl and Piezo1Runx2Cremice after
Masson-Goldner trichrome staining. (C) Quantification of the PZ, HZ, and TW in 12-week-old female Piezo1fl (n= 6) and Piezo1Runx2Cremice (n= 6). (D) Quan-
tification of the B.Ar comprising the PS and SS in the same animals. (E) Number of osteoclasts (N.Oc/B.Pm) on trabecular bone surfaces in lumbar spine
sections of 12-week-old female Piezo1fl (n = 6) and Piezo1Runx2Cre mice (n = 6). (F) Dynamic histomorphometric analysis of the trabecular BFR/BS and
MAR in the same animals. (G) Serum P1NP and P1CP concentrations in 12-week-old female Piezo1fl (n = 5) and Piezo1Runx2Cremice (n = 6). (H) Quantification
of the number of cuboidal and flattened osteoblasts (N.Ob/B.Pm) in 12-week-old female Piezo1fl (n = 6) and Piezo1Runx2Cre mice (n = 6). (I) Representative
toluidine blue staining of trabecular bone surfaces in lumbar spine sections showing cuboidal osteoblasts (arrowheads) with osteoid (asterisks) in
12-week-old female Piezo1fl mice, as well as cuboidal (left, arrowheads) or flattened osteoblasts (middle, arrowheads) with osteoid (asterisks) and bone
lining cells (right) in 12-week-old female Piezo1Runx2Cre mice. Data are median with interquartile range, whiskers indicate minimum to maximum,
p values obtained by unpaired two-tailed t test. B.Ar = bone area; BFR/BS = bone formation rate per bone surface; GP = growth plate; HZ = hypertrophic
zone; MAR =mineral apposition rate; N.Oc/B.Pm = number of osteoclasts/bone perimeter; PS = primary spongiosa; PZ = proliferative zone; SS = secondary
spongiosa; TW = total growth plate width.
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ossification. Importantly however, whereas the trabecular
bone volume was reduced in these mice (Fig. 5H), their growth
plate morphology was unaffected (Fig. 5I). This was also con-
firmed by immunohistochemistry for type X collagen, where
we additionally made an unexpected observation. More
specifically, whereas type X collagen was only detected in
hypertrophic cartilage and the primary spongiosa in Piezo1fl
control mice, the presumptive osteoblasts of the secondary
spongiosa in Piezo1Runx2Cre mice were also positive for type X
collagen (Fig. 5J).
Fig 7. Col2a1Cre-mediated Piezo1 deletion impairs trabecular bone formation. (A) Representative X-ray images of 2-week-old female Piezo1fl and Piezo1-
Col2a1Cre mice demonstrating multiple rib fractures (empty arrowheads). (B) X-ray images of 12-week-old female Piezo1fl and Piezo1Col2a1Cre mice demon-
strating rib fractures (empty arrowheads) and pelvic dysplasia (arrow). (C) Quantification of rib fractures in female Piezo1Col2a1Cremice at 2 weeks (2w, n= 4)
and 12 weeks (12w, n = 5) of age. (D) X-ray-based quantification of the length of LS, Fe, and Ti in 2-week-old and 12-week-old female Piezo1fl and Piezo1-
Col2a1Cremice. (E) Representative μCT images of cortical (top) and trabecular bone (bottom) from femora of 12-week-old female Piezo1fl (n = 4) and Piezo1-
Col2a1Cre mice (n = 5). Quantification of Ct.Th and trabecular BV/TV is given on the right. (F) Von Kossa staining of lumbar spine (top) and tibia sections
(bottom) from 12-week-old female Piezo1fl and Piezo1Col2a1Cre mice. (G) Quantification of trabecular BV/TV in the LS of 12-week-old female Piezo1fl
(n = 4) and Piezo1Col2a1Cre mice (n = 5). (H) Analysis of the B.Ar comprising the PS and SS in 12-week-old female Piezo1fl (n = 4) and Piezo1Col2a1Cre mice
(n = 5). (I) Quantification of the number of cuboidal and flattened osteoblasts (N.Ob/B.Pm) on trabecular bone surfaces in the LS of the same mice. Data
are eithermedianwith interquartile range, whiskers indicateminimum tomaximumormedian andminimum tomaximum, p values obtained by unpaired
two-tailed t test. B.Ar = bone area; BV/TV = bone volume per tissue volume; Ct.Th = cortical thickness; Fe = femurs; LS = lumbar spine; N.Ob/B.Pm= number
of osteoblasts/bone perimeter; PS = primary spongiosa; SS = secondary spongiosa; Ti = tibias.
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Based on these findings we analyzed the growth plates in tibia
sections from 12-week-old Piezo1fl and Piezo1Runx2Cre littermate
mice (Fig. 6A,B). Here we identified an enlargement of the hyper-
trophic zones in Piezo1Runx2Cre sections, although the difference
toward Piezo1fl controls was moderate (Fig. 6C). Most impor-
tantly, however, whereas the primary spongiosa was unaffected,
the trabecular bone area comprising the secondary spongiosa
was remarkably reduced in Piezo1Runx2Cre mice (Fig. 6D), similar
to what was found in the spine. Although there were only few
trabecular structures present on Piezo1Runx2Cre vertebral sections,
we additionally used these to perform cellular and dynamic his-
tomorphometry. Here we identified an increased osteoclast
number (Fig. 6E) and a moderate reduction in the mineral appo-
sition rate at the trabecular bone surfaces (Fig. 6F). Although
these changes are in principal agreement with recently pub-
lished findings in Piezo1PrxCre mice,(35,36) these histomorpho-
metric data have to be regarded cautiously, given the strong
reduction of trabecular number in Piezo1Runx2Cre bone sections.
The same applies for the serum concentrations of the bone for-
mation biomarkers P1NP and P1CP, that is the amino-terminal
and carboxy-terminal propeptides of type I collagen, that were
found reduced in 12-week-old Piezo1Runx2Cre mice compared to
Piezo1fl littermates (Fig. 6G).
What wasmost evident, however, was a changedmorphology
of Piezo1Runx2Cre osteoblasts, similar to Piezo1Dmp1Cre mice, but
more pronounced. In fact, we detected a threefold increase in
the number of osteoblasts with flattened appearance in
12-week-old Piezo1Runx2Cre mice, when compared to Piezo1fl con-
trols (Fig. 6H). Here it is also important to state that we do not
consider this pathology as an artifact of sectioning, especially
because it was not observed in Piezo2Runx2Cremice or Piezo1Lyz2Cre
mice. Moreover, the unusually flattened osteoblasts in Piezo1-
Runx2Cre mice were clearly distinguishable from bone lining cells,
because they were placed over a layer of osteoid (Fig. 6I). Finally,
the coexistence of cuboidal osteoblasts, flattened osteoblasts,
and lining cells in individual vertebral body sections of Piezo1-
Runx2Cremice further illustrates that this is a unique aspect of their
phenotype. Taken together, our collective findings show that
Piezo1Runx2Cre mice do not display a profound skeletal pathology
at birth, but thereafter they develop a severe phenotype, which
is primarily characterized by impaired formation of the second-
ary spongiosa.
Col2a1Cre-mediated Piezo1 deletion impairs trabecular
bone formation
Because there is increasing evidence supporting the concept
that trabecular bone osteoblasts derive from growth plate pro-
genitor cells,(56,57) the collective data obtained in Piezo1Runx2Cre
mice raised the hypothesis that the impact of Piezo1 on endo-
chondral ossification is mediated by its influence on growth
plate chondrocytes, where Runx2 is also expressed.(58,59) There-
fore, to analyze the impact of Piezo1 inactivation in chondro-
cytes in vivo, we took advantage of Col2a1Cre mice(41) to
generate Piezo1Col2a1Cre animals. Similar to Piezo1Runx2Cre mice,
there was a high incidence of skeletal fractures in Piezo1Col2a1Cre
mice, and 12-week-old animals also displayed pelvic dysplasia
(Fig. 7A–C). We additionally observed a moderate reduction in
the length of different skeletal elements in Piezo1Col2a1Cre mice
(Fig. 7D). By μCT analysis of the femoral bones we observed that
chondrocyte-specific Piezo1 inactivation did not significantly
reduce cortical bone thickness, but that the trabecular bone
volume in Piezo1Col2a1Cre mice was nearly 50% reduced com-
pared to Piezo1fl littermate controls (Fig. 7E).
That chondrocyte expression of Piezo1 is required for trabecu-
lar bone formation was further confirmed by undecalcified his-
tology of vertebral bodies and tibias (Fig. 7F). Here we detected
a significantly reduced trabecular bone volume in Piezo1Col2a1Cre
mice, which was most pronounced in the secondary spongiosa
(Fig. 7G,H). Finally, similar to Piezo1Runx2Cre mice, the number of
flattened osteoblasts was strongly increased in Piezo1Col2a1Cre
animals (Fig. 7I). On the other hand, osteoclast number and min-
eral apposition rate were not significantly different between
12-week-old Piezo1fl and Piezo1Col2a1Cre littermates
(Supplementary Fig. 9), but also in this comparison, the results
have to be regarded cautiously, because there were only a few
trabeculae on Piezo1Col2a1Cre bone sections. Despite this limita-
tion, however, these data show that Piezo1 has a previously
unrecognized function in chondrocytes to promote trabecular
bone formation.
Discussion
Taken together, our findings, obtained through systematic anal-
ysis of mouse models with inactivation of Piezo1 and/or Piezo2
in different skeletal cell populations, revealed that Piezo1 has
two independent functions in osteoblast lineage cells. First,
thereby confirming data by others,(34) Piezo1 is required for
mechanosensation by osteocytes. Second, Piezo1 expression in
chondrocytes is required to generate the secondary spongiosa
and thereby the trabecular bone compartment, a function that
is relevant postnatally, underscored by the lack of a skeletal phe-
notype in newborn Piezo1Runx2Cre mice. Therefore, our study pro-
vides a novel key information regarding the role of Piezo1 in the
skeleton. In fact, based on the combined analyses from different
investigators, which were all published very recently, it is now
evident that mechanosensation through Piezo1 is critical for var-
ious aspects of skeletal development, growth, and remodeling.
It was initially reported that poking-induced mechanical
responses of the osteoblast cell line MC3T3-E1 depend on Piezo1
expression, and that Piezo1OcnCre mice display a low bone mass
phenotype due to decreased bone formation.(33) Because there
was also a diminished response of Piezo1OcnCre mice in the
osteoanabolic response toward treadmill exercise, these data
suggested that Piezo1 is the long-sought mechanoreceptor in
the context of bone remodeling. That this critical function of
Piezo1 depends on its expression in osteocytes was supported
in a second study, which included the generation and analysis
of Piezo1Dmp1Cre mice.(34) Here the authors observed a low bone
mass phenotype associated with spontaneous fracture in 16%
of the animals. They additionally demonstrated that the osteoa-
nabolic response of Piezo1Dmp1Cre mice towards tibia loading is
strongly reduced. Although our own data obtained in Piezo1-
Dmp1Cre mice essentially confirm these previous findings, we
included them as supplemental information, because it is impor-
tant to show that the influence of loading in another skeletal ele-
ment (ie, ulna) also depends on Piezo1 expression in osteocytes.
Moreover, it is further relevant to state that our analysis of the
osteocyte lacunar network in Piezo1Dmp1Cre mice, which has not
been studied previously, revealed nomajor difference compared
to Piezo1fl controls, thereby showing that Piezo1 specifically con-
trols mechanosensation without affecting osteocyte differentia-
tion or morphology. Finally, by additionally generating Piezo1;
Piezo2Dmp1Cre mice, we are able to conclude that the potential
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role of Piezo2 is neglectable in the context of osteocyte-
regulated bone remodeling. This latter notion is also relevant
with respect to our initial in vitro experiments using MC3T3-E1
cells. In fact, our observation that siRNA-mediated knockdown
of Piezo1 did not abolish the LFF-induced Ptgs2 expression is
quite similar to what was found in the osteocyte cell line MLO-
Y4.(34) This implies that Piezo-independent mechanisms have
to exist, which participate in these LFF responses, at least in vitro.
That Piezo1 plays a critical role in the bone modeling phase,
which became the primary focus of our manuscript, was also
reported.(35,36) It was shown that Piezo1Prx1Cre mice, which sub-
stantially differ from the Piezo1Runx2Cremice, because Piezo1 inac-
tivation does not take place in the axial skeleton, display an early-
onset osteoporotic phenotype with a high incidence of sponta-
neous fractures. There are, however, remarkable differences in
the phenotype pathogenesis between the two studies. In fact,
whereas the first study identified excessive osteoclastogenesis
as the major cause of the osteoporotic phenotype in 6-week-
old Piezo1Prx1Cre mice,(35) the second study identified a reduced
bone formation rate in 3-week-old Piezo1Prx1Cremice as themajor
driver of the phenotype.(36) In this regard it is relevant to state
that our histomorphometric analysis of Piezo1Runx2Cre mice,
although this has to be cautiously interpreted (due to a low
amount of bone surfaces in themutant animals), revealed a com-
bination of both cellular phenotype causes. In fact, we identified
a moderately increased osteoclast number together with
reduced mineral apposition rate and serum P1CP concentration
in 12-week-old Piezo1Runx2Cre mice. These findings principally
support the previously established function of Piezo1 in
osteoblast–osteoclast coupling, molecularly explained by
Piezo1-regulated production of Col2a1 and Col9a2 in osteo-
blasts, which in turn inhibit osteoclastogenesis.(35) Importantly,
however, whereas the Piezo1Prx1Cre mice used in the respective
study were found to display a remarkable cortical bone
porosity,(35) this parameter was only moderately increased in
Piezo1Runx2Cre animals. In any case, should there be a critical
impact of Piezo1 on osteoclastogenesis, such an influence is
likely mediated indirectly, because we confirmed that loss of
Piezo1 in the osteoclast lineage (previously studied in Piezo1-
CstkCre mice) does not cause a bone phenotype, and the same
applies for Piezo2. With respect to Prx1Cremodels it is finally rel-
evant to state that a near absence of secondary spongiosa for-
mation was noted in Piezo1;Piezo2Prx1Cre mice, although this
was not considered to be linked to Piezo1 expression in
chondrocytes.(36)
Our focus on the potential role of Piezo1 in growth plate chon-
drocytes was triggered by the unexpected findings obtained by
genomewide expression analysis of primary calvarial osteoblasts
from Piezo1fl and Piezo1Runx2Cre mice, where we identified a
remarkable increase in the expression of chondrogenic markers
in the latter. In particular Sox9, encoding a key transcription fac-
tor promoting chondrogenic and inhibiting osteogenic
differentiation,(50) was the most strongly induced gene in early-
stage Piezo1Runx2Cre osteoblasts. Because we also found an induc-
tion of Col10a1 expression in Piezo1Runx2Cre osteoblasts, together
with a repression of Col10a1 expression by Yoda1 administration
to ATDC5 cells, we performed immunohistochemistry to detect
type X collagen, an established marker for hypertrophic chon-
drocytes. Here we found, in tibia sections from Piezo1Runx2Cre
mice, unlike was the case in Piezo1fl control sections, that the
cells covering the surface of the nearly absent secondary spon-
giosa in Piezo1Runx2Cre mice were positive for type X collagen.
Because there is accumulating evidence that trabecular bone
osteoblasts, at least in the bone modeling phase, are derived
from growth plate chondrocytes,(56,57) these data suggested that
the osteogenic differentiation of these progenitors is impaired in
Piezo1Runx2Cre mice. Our deduced hypothesis that Piezo1 is
required to regulate the differentiation of growth plate osteo-
chondroprogenitor cells was further investigated by the genera-
tion and analysis of Piezo1Col2a1Cre mice. Here we identified, for
the first time, that Piezo1 inactivation in chondrocytes strongly
affects secondary spongiosa formation due to impaired genera-
tion of trabecular osteoblasts, which results in a severe osteopo-
rotic phenotype that is comparable to Piezo1Runx2Cre mice. Since
Runx2 is not only expressed in osteoblast progenitors, but also
in prehypertrophic chondrocytes,(58,59) this phenotypic overlap
between Piezo1Col2a1Cre and Piezo1Runx2Cre mice is concordant.
Importantly however, future research toward the potential role
of Piezo1 in the transdifferentiation of growth plate chondro-
cytes into trabecular osteoblasts, with for instance lineage trac-
ing studies, is required to ultimately confirm our findings based
on the phenotypes of Piezo1Runx2Cre and Piezo1Col2a1Cre mice.
It is also still required to understand the molecular mecha-
nisms that explain how mechanosensation by Piezo1 is trans-
lated into a regulation of osteochondrogenic differentiation.
However, because it may require complex cellular interactions
controlled by specific mechanical forces that only exist in the
in vivo setting, such an influence might be difficult to recapitu-
late in vitro. Therefore, although we truly believe in the value
of cell culture systems to generate hypotheses, the respective
results might not generally relate to the physiological situation.
In our case it was for instance surprising that we identified
increased expression of chondrogenic markers in Piezo1Runx2Cre
primary calvarial osteoblasts, although we retrospectively dis-
covered that even newborn Piezo1Runx2Cre mice do not display a
calvarial bone phenotype. Similarly, although an altered osteo-
blast morphology was one of the most obvious pathologies
observed in Piezo1Runx2Cre bone sections, we did not detect an
obvious impact of Piezo1 inactivation on morphology and cyto-
skeletal organization in cultured MC3T3-E1 cells or primary
osteoblasts.
It is also noteworthy that our initial transcriptomic analyses
did not pick up several previously established Piezo1 target
genes.(33–35) The strongest induction that we observed was
related to Cyr61, which was more than sixfold induced in
MC3T3-E1 cells 4 hours after LFF, similar to what has been
reported for the osteocyte cell line MLO-Y4.(34) What we did
not observe, however, unlike was reported for MLO-Y4 cells,
was an induction of Wnt1 expression by either LFF or Yoda1.
Because Wnt1 induction in osteocytes has been suggested to
be essential for translating the Piezo1-mediated mechanical
response into increased bone formation,(60) the absence of
Wnt1 induction in osteoblasts is a potentially relevant finding.
In this regard it is further important to state that we have previ-
ously studied the skeletal phenotype ofWnt1Runx2Cremice, which
displayed reduced bonemass and spontaneous fractures, but no
impairment of secondary spongiosa formation.(61) This essen-
tially demonstrates that Wnt1 is not a relevant downstream
mediator of Piezo1 in the context of endochondral ossification,
thereby further supporting our conclusion that Piezo1 has dis-
tinct functions in osteocytes and osteoprogenitor cells.
Although several questions regarding the role of Piezo1 in
skeletal biology remain to be addressed, it is now evident, based
on the combined data accumulated by different investigators,
that Piezo1 is required for promoting bone formation in both,
the modeling and remodeling phase. In this context it is highly
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relevant that another recent study has confirmed that genetic
variation in PIEZO1 is associated with bone mineral density and
fracture risk in humans.(62) Therefore, PIEZO1 can be regarded
as a potential osteoanabolic drug target for the treatment of
skeletal disorders, including osteoporosis. Given the broad
expression and the pleiotropic role of PIEZO1 in various cell
types, it is surely debatable, if selective PIEZO1 activation
would specifically enhance skeletal development or remodel-
ing. However, because osteoporosis is most frequently
observed in elderly patients, often associated with low physical
activity, it is certainly worthwhile to optimize PIEZO1-specific
agonism. Here it is important to state that treatment with the
Piezo1-agonist Yoda1 was previously shown to increase bone
formation in wild-type mice, albeit only marginally.(34) Because
this might be explained by suboptimal pharmacokinetic prop-
erties of Yoda1, the development of new Piezo1 activa-
tors(63,64) should certainly be intensified and assessed in vivo
in the near future.
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